SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016539
Filing Date
2017-08-08
Accepted
2017-08-08 16:17:25
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20170630.htm 10-Q 1534224
2 EX-31.1 fprx-ex311_7.htm EX-31.1 8506
3 EX-31.2 fprx-ex312_6.htm EX-31.2 8502
4 EX-32.1 fprx-ex321_10.htm EX-32.1 5346
5 EX-32.2 fprx-ex322_8.htm EX-32.2 5237
6 GRAPHIC g201708081815097662688.jpg GRAPHIC 58695
  Complete submission text file 0001564590-17-016539.txt   4746638

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fprx-20170630.xml EX-101.INS 1040987
8 XBRL TAXONOMY EXTENSION SCHEMA fprx-20170630.xsd EX-101.SCH 24839
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20170630_cal.xml EX-101.CAL 41939
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20170630_def.xml EX-101.DEF 67753
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20170630_lab.xml EX-101.LAB 224272
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20170630_pre.xml EX-101.PRE 162220
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 171014987
SIC: 2834 Pharmaceutical Preparations